NKAPL
gene geneOn this page
Also known as bA424I5.1
Summary
NKAPL (NFKB activating protein like, HGNC:21584) is a protein-coding gene on chromosome 6p22.1, encoding NKAP-like protein (Q5M9Q1). Transcriptional repressor of Notch-mediated signaling.
Predicted to enable chromatin binding activity. Predicted to be involved in regulation of gene expression. Predicted to be active in nucleus.
Source: NCBI Gene 222698 — RefSeq curated summary.
At a glance
- GWAS associations: 21
- Clinical variants (ClinVar): 51 total
- MANE Select transcript:
NM_001007531
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:21584 |
| Approved symbol | NKAPL |
| Name | NFKB activating protein like |
| Location | 6p22.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | bA424I5.1 |
| Ensembl gene | ENSG00000189134 |
| Ensembl biotype | protein_coding |
| Entrez | 222698 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000343684
RefSeq mRNA: 1 — MANE Select: NM_001007531
NM_001007531
CCDS: CCDS34353
Canonical transcript exons
ENST00000343684 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001384451 | 28259297 | 28260958 |
Expression profiles
Bgee: expression breadth ubiquitous, 187 present calls, max score 92.53.
FANTOM5 (CAGE): breadth broad, TPM avg 1.5751 / max 72.0470, expressed in 646 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 66620 | 1.5264 | 631 |
| 66621 | 0.0488 | 15 |
Top tissues by expression
239 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| buccal mucosa cell | CL:0002336 | 92.53 | gold quality |
| sperm | CL:0000019 | 89.72 | gold quality |
| left testis | UBERON:0004533 | 88.71 | gold quality |
| right testis | UBERON:0004534 | 88.17 | gold quality |
| testis | UBERON:0000473 | 86.98 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 84.31 | silver quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.81 | gold quality |
| pancreatic ductal cell | CL:0002079 | 81.01 | silver quality |
| pons | UBERON:0000988 | 78.20 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 76.96 | gold quality |
| vena cava | UBERON:0004087 | 76.59 | silver quality |
| medial globus pallidus | UBERON:0002477 | 76.46 | silver quality |
| myocardium | UBERON:0002349 | 76.35 | gold quality |
| gastrocnemius | UBERON:0001388 | 75.74 | gold quality |
| muscle of leg | UBERON:0001383 | 75.38 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 75.25 | gold quality |
| globus pallidus | UBERON:0001875 | 75.06 | silver quality |
| tendon of biceps brachii | UBERON:0008188 | 74.97 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 74.48 | gold quality |
| muscle tissue | UBERON:0002385 | 74.42 | gold quality |
| heart left ventricle | UBERON:0002084 | 73.80 | gold quality |
| cardiac ventricle | UBERON:0002082 | 73.67 | gold quality |
| inferior vagus X ganglion | UBERON:0005363 | 73.20 | gold quality |
| primary visual cortex | UBERON:0002436 | 73.00 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 72.77 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 72.41 | silver quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 72.39 | silver quality |
| occipital lobe | UBERON:0002021 | 72.36 | gold quality |
| ventral tegmental area | UBERON:0002691 | 72.19 | silver quality |
| heart | UBERON:0000948 | 72.15 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-53 | no | 37.88 |
| E-ANND-3 | no | 2.31 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
34 targeting NKAPL, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-548AT-5P | 99.96 | 70.83 | 2666 |
| HSA-MIR-5688 | 99.96 | 73.23 | 4504 |
| HSA-MIR-495-3P | 99.96 | 72.81 | 4197 |
| HSA-MIR-7-1-3P | 99.91 | 71.53 | 4384 |
| HSA-MIR-7-2-3P | 99.91 | 71.40 | 4394 |
| HSA-MIR-5582-3P | 99.86 | 72.48 | 4221 |
| HSA-MIR-5003-3P | 99.85 | 69.29 | 2517 |
| HSA-MIR-3609 | 99.52 | 69.89 | 2587 |
| HSA-MIR-548AH-5P | 99.52 | 69.73 | 2626 |
| HSA-MIR-4489 | 99.50 | 65.56 | 785 |
| HSA-MIR-1275 | 99.47 | 67.90 | 2749 |
| HSA-MIR-208A-5P | 99.42 | 70.83 | 1913 |
| HSA-MIR-208B-5P | 99.42 | 70.83 | 1952 |
| HSA-MIR-5587-5P | 99.07 | 68.58 | 838 |
| HSA-MIR-5583-3P | 99.06 | 65.68 | 1018 |
| HSA-MIR-625-5P | 99.02 | 68.64 | 2031 |
| HSA-MIR-4260 | 98.78 | 65.37 | 848 |
| HSA-MIR-5572 | 98.55 | 65.84 | 970 |
| HSA-MIR-4778-5P | 97.96 | 68.06 | 1634 |
| HSA-MIR-4665-5P | 97.91 | 67.69 | 1536 |
| HSA-MIR-450A-2-3P | 97.91 | 67.56 | 1459 |
| HSA-MIR-6893-3P | 97.79 | 64.91 | 1238 |
| HSA-MIR-643 | 97.35 | 67.91 | 805 |
| HSA-MIR-370-3P | 97.09 | 64.92 | 1221 |
| HSA-MIR-3126-5P | 96.87 | 65.83 | 912 |
| HSA-MIR-6875-5P | 96.87 | 65.49 | 958 |
| HSA-MIR-664B-5P | 96.74 | 67.50 | 509 |
Literature-anchored findings (GeneRIF, showing 6)
- Genome-wide association study identifies a susceptibility locus for schizophrenia in Han Chinese at 11p11.2. (PMID:22037552)
- Fine-mapping analyses identified six NKAPL locus variants in a single haplotype block showing association with rheumatoid arthritis. (PMID:23223422)
- Study suggested that rs1635 in the NKAPL gene appeared to play a role in conferring susceptibility to schizophrenia (PMID:24972756)
- Overexpression of NKAPL in germline stem cells demonstrated that Nkapl induced changes in spermatogonial stem cell (SSC) markers and the reduction of differentiation factors through the Notch signaling pathway. (PMID:25875095)
- further evidence for the involvement of NKAPL polymorphisms in the development of schizophrenia. (PMID:26297123)
- Single nucleotide polymorphism in NKAPL is associated with atherosclerosis. (PMID:28095483)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | nkap | ENSDARG00000033450 |
| mus_musculus | Nkapl | ENSMUSG00000059395 |
| rattus_norvegicus | Nkapl | ENSRNOG00000056708 |
| drosophila_melanogaster | CG6066 | FBGN0039488 |
| caenorhabditis_elegans | let-504 | WBGENE00002696 |
Paralogs (1): NKAP (ENSG00000101882)
Protein
Protein identifiers
NKAP-like protein — Q5M9Q1 (reviewed: Q5M9Q1)
All UniProt accessions (1): Q5M9Q1
UniProt curated annotations — full annotation on UniProt →
Function. Transcriptional repressor of Notch-mediated signaling. Required for spermatogenesis.
Subunit / interactions. Interacts with RBPJ, CIRSR and HDAC3.
Subcellular location. Nucleus.
Similarity. Belongs to the NKAP family.
RefSeq proteins (1): NP_001007532* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR009269 | NKAP_C | Domain |
| IPR040466 | NKAP | Family |
Pfam: PF06047, PF15692
UniProt features (16 total): compositionally biased region 7, sequence variant 4, region of interest 2, modified residue 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5M9Q1-F1 | 60.21 | 0.09 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (2): 23, 148
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 41 (showing top):
GOBP_MALE_GAMETE_GENERATION, SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, GOMF_CHROMATIN_BINDING, WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D, EIF4E_DN, ZNF618_TARGET_GENES, MIR548AT_5P, MIR1275, MIR4778_5P, MIR4665_5P, MIR5587_5P, MIR4489, GSE13738_RESTING_VS_TCR_ACTIVATED_CD4_TCELL_UP, GSE13738_RESTING_VS_BYSTANDER_ACTIVATED_CD4_TCELL_UP
GO Biological Process (3): spermatogenesis (GO:0007283), regulation of gene expression (GO:0010468), cell differentiation (GO:0030154)
GO Molecular Function (2): chromatin binding (GO:0003682), protein binding (GO:0005515)
GO Cellular Component (1): nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 2 |
| developmental process involved in reproduction | 1 |
| male gamete generation | 1 |
| gene expression | 1 |
| regulation of macromolecule biosynthetic process | 1 |
| cellular developmental process | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
824 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| NKAPL | ZKSCAN4 | Q969J2 | 723 |
| NKAPL | ZKSCAN8 | Q15776 | 646 |
| NKAPL | ZSCAN9 | O15535 | 614 |
| NKAPL | ZSCAN16 | Q9H4T2 | 608 |
| NKAPL | PGBD1 | Q96JS3 | 596 |
| NKAPL | ZSCAN26 | Q16670 | 574 |
| NKAPL | ZSCAN31 | Q96LW9 | 512 |
| NKAPL | ZNF165 | P49910 | 477 |
| NKAPL | TSPAN18 | Q96SJ8 | 468 |
| NKAPL | ZKSCAN3 | Q9BRR0 | 437 |
| NKAPL | OR10K2 | Q6IF99 | 434 |
| NKAPL | ZNF438 | Q7Z4V0 | 406 |
| NKAPL | ZBTB41 | Q5SVQ8 | 405 |
| NKAPL | ZNF510 | Q9Y2H8 | 405 |
| NKAPL | ZNF646 | O15015 | 399 |
| NKAPL | ZNF546 | Q86UE3 | 399 |
IntAct
33 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| NKAP | NOS1AP | psi-mi:“MI:0914”(association) | 0.660 |
| NKAPL | DDX41 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ARL6IP4 | NKAPL | psi-mi:“MI:0915”(physical association) | 0.560 |
| NKAPL | ZNF417 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NKAPL | CLK3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NKAPL | SREK1IP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NKAPL | ZNF587 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NKAPL | NKAPD1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NKAPL | TNFRSF10D | psi-mi:“MI:0915”(physical association) | 0.400 |
| NKAPL | CSNK2A2 | psi-mi:“MI:0915”(physical association) | 0.400 |
| NKAPL | psi-mi:“MI:0915”(physical association) | 0.370 | |
| CUL2 | ANXA2P2 | psi-mi:“MI:0914”(association) | 0.350 |
| NKAP | C1orf226 | psi-mi:“MI:0914”(association) | 0.350 |
| MAPK1 | SEC16A | psi-mi:“MI:0914”(association) | 0.350 |
| NKAPL | DDX41 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF417 | NKAPL | psi-mi:“MI:0915”(physical association) | 0.000 |
| SREK1IP1 | NKAPL | psi-mi:“MI:0915”(physical association) | 0.000 |
| ARL6IP4 | NKAPL | psi-mi:“MI:0915”(physical association) | 0.000 |
| NKAPL | CLK3 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF587 | NKAPL | psi-mi:“MI:0915”(physical association) | 0.000 |
| NKAPD1 | NKAPL | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (27): NKAPL (Affinity Capture-MS), NKAPL (Two-hybrid), NKAPL (Two-hybrid), NKAPL (Two-hybrid), NKAPL (Two-hybrid), NKAPL (Two-hybrid), NKAPL (Two-hybrid), ZNF587 (Two-hybrid), NKAPL (Affinity Capture-MS), NKAPL (Affinity Capture-MS), NKAPL (Affinity Capture-MS), NKAPL (Affinity Capture-MS), NKAPL (Affinity Capture-MS), TNFRSF10D (Affinity Capture-MS), CSNK2A2 (Affinity Capture-MS)
ESM2 similar proteins: A2RTL5, A6QLS2, B2RY56, O15042, P30189, P30640, P34433, P34594, P49756, Q10580, Q28C44, Q2TBE0, Q3LSS0, Q4V7C9, Q4X1D7, Q502P0, Q5M9I6, Q5M9Q1, Q5PQR4, Q5R7X2, Q5R814, Q5R8J6, Q5VTL8, Q5XHJ5, Q6AXY7, Q6DDA4, Q6DH74, Q6GLZ8, Q6NV83, Q6NWI1, Q6P7Y3, Q7L4I2, Q7SI59, Q7ZVW9, Q7ZYR8, Q80SY5, Q8GXN9, Q8IMP6, Q8N5F7, Q99LX5
Diamond homologs: Q4P4G8, Q4V7C9, Q55ED4, Q5M9Q1, Q5SZT7, Q8N5F7, Q9D0F4, Q9VB74
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
51 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 50 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
77 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 6:28260297:C:G | donor_gain | 0.8900 |
| 6:28260296:GC:G | donor_gain | 0.8600 |
| 6:28260282:AAG:A | donor_gain | 0.7800 |
| 6:28260296:GCTGA:G | donor_gain | 0.7000 |
| 6:28260280:TGA:T | donor_gain | 0.6900 |
| 6:28260291:C:G | donor_gain | 0.6900 |
| 6:28260301:G:GG | donor_gain | 0.6800 |
| 6:28260347:TTGAC:T | donor_gain | 0.6500 |
| 6:28260287:GC:G | donor_gain | 0.6200 |
| 6:28260299:GA:G | donor_gain | 0.6200 |
| 6:28260316:A:T | donor_gain | 0.5800 |
| 6:28260253:G:GT | donor_gain | 0.5600 |
| 6:28260295:GGC:G | donor_gain | 0.5400 |
| 6:28260256:G:GG | donor_gain | 0.5300 |
| 6:28260255:A:AG | donor_gain | 0.4800 |
| 6:28260387:A:AG | donor_gain | 0.4700 |
| 6:28260297:C:CG | donor_gain | 0.4600 |
| 6:28260384:GT:G | donor_gain | 0.4200 |
| 6:28260385:TT:T | donor_gain | 0.4200 |
| 6:28259711:G:GT | donor_gain | 0.4100 |
| 6:28260337:TG:T | donor_gain | 0.4000 |
| 6:28260386:T:A | donor_gain | 0.3900 |
| 6:28259742:A:T | donor_gain | 0.3800 |
| 6:28260281:GAA:G | donor_gain | 0.3800 |
| 6:28260300:A:AG | donor_gain | 0.3700 |
| 6:28260304:T:A | donor_gain | 0.3700 |
| 6:28259630:T:TA | acceptor_gain | 0.3500 |
| 6:28260340:A:G | donor_gain | 0.3500 |
| 6:28260577:G:GG | donor_gain | 0.3500 |
| 6:28260184:G:GA | donor_gain | 0.3400 |
AlphaMissense
2655 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 6:28260324:T:C | I318T | 0.998 |
| 6:28260439:G:C | K356N | 0.998 |
| 6:28260439:G:T | K356N | 0.998 |
| 6:28260394:G:A | M341I | 0.996 |
| 6:28260394:G:C | M341I | 0.996 |
| 6:28260394:G:T | M341I | 0.996 |
| 6:28260395:A:C | S342R | 0.996 |
| 6:28260397:T:A | S342R | 0.996 |
| 6:28260397:T:G | S342R | 0.996 |
| 6:28260417:T:C | M349T | 0.996 |
| 6:28260422:G:C | A351P | 0.996 |
| 6:28260393:T:C | M341T | 0.995 |
| 6:28260434:C:A | R355S | 0.995 |
| 6:28260435:G:C | R355P | 0.995 |
| 6:28260334:A:C | R321S | 0.994 |
| 6:28260334:A:T | R321S | 0.994 |
| 6:28260437:A:C | K356Q | 0.994 |
| 6:28260376:A:C | E335D | 0.993 |
| 6:28260376:A:T | E335D | 0.993 |
| 6:28260432:T:C | L354P | 0.993 |
| 6:28260442:G:C | E357D | 0.993 |
| 6:28260442:G:T | E357D | 0.993 |
| 6:28260447:A:C | Q359P | 0.993 |
| 6:28260296:G:C | A309P | 0.992 |
| 6:28260399:G:A | G343D | 0.992 |
| 6:28260455:A:C | S362R | 0.992 |
| 6:28260457:T:A | S362R | 0.992 |
| 6:28260457:T:G | S362R | 0.992 |
| 6:28260333:G:C | R321T | 0.991 |
| 6:28260333:G:T | R321I | 0.991 |
dbSNP variants (sampled 300 via entrez): RS1001245941 (6:28257706 A>G), RS1001676006 (6:28258016 C>T), RS1002705275 (6:28260800 G>A), RS1003970067 (6:28259258 C>T), RS1005643066 (6:28261150 T>G), RS1005732514 (6:28260633 A>G), RS1006888200 (6:28261215 T>C), RS1007559388 (6:28260941 GT>G,GTT), RS1010357235 (6:28258425 C>G,T), RS1011013323 (6:28259063 A>G), RS1011957292 (6:28259669 T>G), RS1012086969 (6:28261183 T>C), RS1013940372 (6:28257390 G>A), RS1014966600 (6:28259280 C>A,G), RS1015136755 (6:28257563 A>C,T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
21 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001299_1 | Schizophrenia | 7.000000e-12 |
| GCST004521_112 | Autism spectrum disorder or schizophrenia | 3.000000e-26 |
| GCST004521_115 | Autism spectrum disorder or schizophrenia | 3.000000e-16 |
| GCST004521_166 | Autism spectrum disorder or schizophrenia | 4.000000e-24 |
| GCST004521_212 | Autism spectrum disorder or schizophrenia | 5.000000e-14 |
| GCST004521_23 | Autism spectrum disorder or schizophrenia | 2.000000e-11 |
| GCST004521_6 | Autism spectrum disorder or schizophrenia | 2.000000e-15 |
| GCST004521_7 | Autism spectrum disorder or schizophrenia | 2.000000e-15 |
| GCST004521_73 | Autism spectrum disorder or schizophrenia | 8.000000e-11 |
| GCST004521_77 | Autism spectrum disorder or schizophrenia | 1.000000e-19 |
| GCST008921_4 | Asthma and major depressive disorder | 2.000000e-11 |
| GCST008921_6 | Asthma and major depressive disorder | 1.000000e-09 |
| GCST010002_50 | Refractive error | 4.000000e-34 |
| GCST010142_16 | Fish- and plant-related diet | 2.000000e-10 |
| GCST010142_19 | Fish- and plant-related diet | 4.000000e-10 |
| GCST010142_34 | Fish- and plant-related diet | 7.000000e-09 |
| GCST010142_35 | Fish- and plant-related diet | 8.000000e-09 |
| GCST010142_42 | Fish- and plant-related diet | 1.000000e-08 |
| GCST010142_7 | Fish- and plant-related diet | 3.000000e-12 |
| GCST010702_75 | Subcortical volume (MOSTest) | 3.000000e-11 |
| GCST010703_272 | Brain morphology (MOSTest) | 7.000000e-16 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0008111 | diet measurement |
| EFO:0004346 | neuroimaging measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
7 total (human), top 7 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | increases expression, increases methylation | 2 |
| bisphenol A | affects cotreatment, increases methylation, decreases methylation | 1 |
| sodium arsenite | decreases expression | 1 |
| Fulvestrant | affects cotreatment, increases methylation | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.